Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202510016 | Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215421013 | Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478570010 | Aspirin+butalbital+caffeine 325mg/50mg/40mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490394016 | Product containing aspirin 325 mg and butalbital 50 mg and caffeine 40 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494167016 | Product containing aspirin 325 mg and butalbital 50 mg and caffeine 40 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501590010 | Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3569124010 | Product containing only aspirin 325 mg and butalbital 50 mg and caffeine 40 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569125011 | Product containing only aspirin 325 mg and butalbital 50 mg and caffeine 40 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3676785016 | Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3676786015 | Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing caffeine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing butalbital | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Aspirin compound preparation | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing caffeine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Caffeine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Bronchodilator | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Stimulant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Aspirin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Butalbital | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Xanthine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing aspirin and butalbital and caffeine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Substance with phosphodiesterase inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Xanthine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing caffeine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing aspirin in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Aspirin | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has basis of strength substance | Aspirin | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 325 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Butalbital | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has basis of strength substance | Butalbital | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has active ingredient | Caffeine | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has basis of strength substance | Caffeine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 40 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has precise active ingredient | Butalbital | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing aspirin and butalbital and caffeine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has precise active ingredient | Aspirin | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has precise active ingredient | Caffeine | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Is a | Product containing only aspirin and butalbital and caffeine in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has basis of strength substance | Butalbital | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has precise active ingredient | Aspirin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has basis of strength substance | Aspirin | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral tablet | Has precise active ingredient | Butalbital | true | Inferred relationship | Existential restriction modifier | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR